What you need to know about the coronavirus vaccine: ‘It’s the first time we’ve seen it as a mass-produced product’

Updated December 15, 2017 14:57:35As the global pandemic winds down, it seems the world is finally getting a good dose of the coronabovirus vaccine.

A massive vaccine trial in Australia is now underway.

It is designed to help the world reach its peak vaccination rate of 100% by 2025.

The National Health and Medical Research Council (NHMRC) is the federal government agency that manages the program, and it is looking for volunteers to help in the study.

It said it would be “comprehensive” and cost “substantial” to implement.

“The goal of the trial is to assess whether the vaccine is safe and effective and to determine whether it will be effective in controlling COVID-19,” the NHMRC said in a statement.

The vaccine trials are being conducted in a “closed clinical trial” format, with all participants having to take part in an active trial for at least one month.

This means the study is not open to the public.

But it is open to all who wish to participate.

“To encourage participation, the NHMMRC has set up a website and social media accounts to provide additional information and information on the trial, which will be available on the NHMC’s website and NHMCR website,” the statement said.

The trial will involve up to 2,000 volunteers, of whom around 100 will be eligible to be vaccinated.

More than 200 participants have already registered.

The study is being overseen by the Australian Vaccine Authority, and the trial involves volunteers who will be given the vaccine and will be asked to complete daily diary-like surveys to record their vaccination history.

More about coronaviruses, coronavirodiverts, coronacovirus, vaccine source Google Search